{"name":"Clarity Pharmaceuticals Ltd","slug":"clarity-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"clarity.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"64Cu-SAR-bisPSMA","genericName":"64Cu-SAR-bisPSMA","slug":"64cu-sar-bispsma","indication":"PET imaging of PSMA-positive prostate cancer","status":"phase_3"},{"name":"67Cu-SAR-bisPSMA","genericName":"67Cu-SAR-bisPSMA","slug":"67cu-sar-bispsma","indication":"Prostate cancer","status":"phase_1"}]}],"pipeline":[{"name":"64Cu-SAR-bisPSMA","genericName":"64Cu-SAR-bisPSMA","slug":"64cu-sar-bispsma","phase":"phase_3","mechanism":"64Cu-SAR-bisPSMA is a copper-64 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.","indications":["PET imaging of PSMA-positive prostate cancer","Detection and localization of metastatic prostate cancer lesions"],"catalyst":""},{"name":"67Cu-SAR-bisPSMA","genericName":"67Cu-SAR-bisPSMA","slug":"67cu-sar-bispsma","phase":"phase_1","mechanism":"PSMA-targeting radioligand","indications":["Prostate cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-08","type":"deal","source":"The Times of India","summary":"India-US trade deal: Interim pact brings 'certainty and clarity' for pharma sector - The Times of India","headline":"India-US trade deal: Interim pact brings 'certainty and clarity' for pharma sector","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-30","type":"pipeline","source":"simplywall.st","summary":"Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit as were institutions - simplywall.st","headline":"Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-09","type":"pipeline","source":"simplywall.st","summary":"Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near? - simplywall.st","headline":"Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOdXlYRWFHZFNjNkx1NGpUVzVqLUNzZkV3WEFWdjV6enVGSzF0Wmswc2JXQWJRTTZPdTRvUUMtSEdfTmppdFk0REduZlJSYjA4U1VUZjU4WUdNNnVBSy14X3BjTEJjb0dVVk1qN1JPWGowa3VoNjZmQXJBbFdYdWYydjlQX2tzMEtBeU1FTF9LS19yQUdMbjR6ZVdMM1VEb2xLQXprLWtaSUNqM0Y4NzlfRXZR?oc=5","date":"2025-12-09","type":"pipeline","source":"Kalkine Media","summary":"Clarity Pharmaceuticals (ASX:CU6) Poised for Breakthrough Performance - Kalkine Media","headline":"Clarity Pharmaceuticals (ASX:CU6) Poised for Breakthrough Performance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPSTM5Nk80NWJFdDVGUGZDdzBnb3JtVDB2c05DYXZ3N1k1ZFJ6Y0Z5Wi1TdHJhZlgxOXRqSDg0MGREWWpYQkZ3YVBwSmpRNENnQUlXdkxfbTFRR3hob2dKY2l0RTktOE9fS2RseFRjSDBCM1BJalJXUjEtcWgtNjRheEhkWjNkeFluekpFLVlEQ1k5eUkw?oc=5","date":"2025-11-03","type":"pipeline","source":"The Guardian","summary":"We need clarity on big pharma’s tax breaks | Letters - The Guardian","headline":"We need clarity on big pharma’s tax breaks | Letters","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUXh1bDlRcFphdnZweU1ScUpvNHZDMkNPM3RGUmZPcDlvRHN4cnd4QWlzcmJqYmxBNkJ6elIybUtnV3FDdjkwZE1WUGpsbkdJMmVzZGFuYVlOWHp1YjlIaG5ZT0EzeW9aWXZIUUV3LVNOd1YyOHlhMzFGcDJMc0wxUDUxTXFUeFRa?oc=5","date":"2025-10-28","type":"pipeline","source":"Yahoo Finance","summary":"Clarity Pharmaceuticals Ltd (ASX:CU6) Is Expected To Breakeven In The Near Future - Yahoo Finance","headline":"Clarity Pharmaceuticals Ltd (ASX:CU6) Is Expected To Breakeven In The Near Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOeW5GQm1Ea0J0d2VucUxObmtad1BFMDk1bjRHeVg3UUdQNDItdWxFUUItTnpBRHJxX3Y1dlN1eS0xd1lWVGhycGdWTGlTblA3dGNiYjJYaDhKSTJ5ME8yWU5mY1VmUGJVRlpsejNaOW5ZdllVYkk5OWI5b0s1UVBVWklhY1RmZWlGOUZCNDBMTWpiajlaeDFzX3JWUm82R043Y3YtcUlwMDM3M2JzWWhr?oc=5","date":"2025-10-07","type":"deal","source":"ING THINK economic and financial analysis | ING THINK","summary":"Why the Pfizer-Trump pharma deal is a win for branded pharma, but not for consumers - ING THINK economic and financial analysis | ING THINK","headline":"Why the Pfizer-Trump pharma deal is a win for branded pharma, but not for consumers - ING THINK economic and financial a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNSHJMazhjSUdZRzc3YzdUNDJpX0ljODZ5Q3pnb2tXaElGZ1FvTU1OXzhXV2o3UDE5Q1cwa3FINkhBSTBIcEo2cmRIRUlDNVRoQXVTMGRhS2wtSk12b2xNUVpLVWJhTzJxcFJGVUx1SUNoak85eHFNbkJTLXprNllET0t1RTZUb0RGMzl6QQ?oc=5","date":"2025-08-29","type":"pipeline","source":"Yahoo Finance","summary":"Both individual investors who control a good portion of Clarity Pharmaceuticals Ltd (ASX:CU6) along with institutions must be dismayed after last week's 12% decrease - Yahoo Finance","headline":"Both individual investors who control a good portion of Clarity Pharmaceuticals Ltd (ASX:CU6) along with institutions mu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNQnRmZS1HWXNTc1hFR0dPVnNtZXlFQkVvb3ZZa3VNaGVRczIxeXZEOUxvY21KWDEzM1ZSQ00xdzR5ZmJsSWE0WUtFSWd5QUVrOUxVRWcteU9yaFZhcjNhUGpsa0JFaXdHbm1YbDlVTkxfMXRxa01GV2NGc18weU9jeE5seUlhNHVISzEyZkE3cWVuZkZOSXpvN0ZhaDNRemNMUGE3RnV5WUQzZ0RWQmpYcHM1anJNWlhtcWVVODVham04UXN5UFdRR0llbUE0QTh2c2pwTDZXYi1FTjk2MHJjOXlB?oc=5","date":"2025-08-15","type":"pipeline","source":"Stockhead","summary":"Dr Boreham's Crucible: Clarity is a clear and strong contender in the prostate cancer treatment race - Stockhead","headline":"Dr Boreham's Crucible: Clarity is a clear and strong contender in the prostate cancer treatment race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbkZwcEIzRXp2TldnV2Rla1ZsUEtwS3dTd2t3WGp0dFVfMDc5Z25ZRUhBbUY1eTl4MTViLWJBWV9TQmZ2OEJWeVZXUG1iVnJZMUtncmhYN2MtWGNJbi1FekMxVUh1dU9GeTdfeUhNaEhkdmM3bnBkMGdxVW1QLTUxQXUwSTFnaHlBbDUtME9NeE81Szg1elBNZWFfV1dlNENSNEQwM0JXUzFNYVJxNkpiTkxINkRDeUpEYl8yM2MzTklEbG8?oc=5","date":"2025-08-05","type":"pipeline","source":"AFR","summary":"Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance - AFR","headline":"Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxObzRzZ25lUVpfaVk5eDZKRGNLMFczSTd5S0llajhLOWJSNE9VUU9HQmR4VGEyMzRrSGRBYU1MMk9hV2J1dVY4LVBMMHFObFdMNHF2eExUY1E3RjJWZWFBWVZnNGVfZ1g4M1hWUkJ1LWNxV1hLVVZGdEZNZTduVXJnTkNHclk3aXdINGZ6U0FSRHRtTHpJczNzbkJZbXpnc21mNUpLXzNNcGNTdlk?oc=5","date":"2025-07-29","type":"pipeline","source":"BioWorld News","summary":"Clarity raises AU$203M to advance copper-based radiopharma pipeline - BioWorld News","headline":"Clarity raises AU$203M to advance copper-based radiopharma pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOcFUtR056U3g2UUZCVXJOVzZoZVVqVFhzRDZ4RWoyMjNMUDF5QUxlNVk4RTFjcEV4bXIxWS1Sd0JVMXhCWXA2Q0tEbTBZMWswMmpjeWxIYnA2ZmwtRE1TX3FoZ2czMWNZMWRWa0xTVkJ0Q1oyZHVpMkd6MWU3NllTVUdRRXcyekxGaENIYUlnbE8yRkRpXzdtTFRITExBeGRraUQwNTlSTU8zSGN5RXJMYTlYSkJXSUlPMHc?oc=5","date":"2025-06-11","type":"pipeline","source":"Pharmaceutical Technology","summary":"Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’ - Pharmaceutical Technology","headline":"Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}